Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    18005144 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day
2 Completed Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day

Study has passed its completion date and status has not been verified in more than two years.